Inovio Pharmaceuticals Inc vs McCormick & Company, Incorporated — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while McCormick & Company, Incorporated trades at $52.75 (market cap $14.22B). The key difference: McCormick & Company, Incorporated is far larger — about 181× Inovio Pharmaceuticals Inc's market cap, and McCormick & Company, Incorporated pays a 3.63% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | MKC | |
|---|---|---|
Market Cap | $78.55M | $14.22B |
Sector | Health | Consumer Staples |
52-Week High | $2.87 | $72.26 |
52-Week Low | $0.66 | $45.60 |
Enterprise Value | $49.56M | $18.82B |
Dividend Yield | — | 3.63% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →In its 130-year history, McCormick has grown to become the leading global manufacturer, marketer, and distributor of spices, herbs, extracts, seasonings, and other flavorings. Beyond end consumers, McCormick's customer base also includes top quick-service restaurants, retail grocery chains, and other packaged food and beverage manufacturers, with about 30% of sales generated beyond its home turf to include 150 other countries and territories. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and the recently acquired Cholula brand.
Read more on MKC →